Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

NCT00681343 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Living-Donor Kidney Transplant

Interventions

DRUG: Thymoglobulin
DRUG: Campath-1H
DRUG: Daclizumab

Sponsor

University of Miami

Collaborators

[object Object]